白藜芦醇在糖尿病治疗中的作用

白藜芦醇(resveratrol)是一种从植物中提取的多酚类化合物,它广泛存在于葡萄等植物中。白藜芦醇具有广泛的生物学活性,抗氧化、抗癌和调节代谢等作用。白藜芦醇在治疗糖尿病(diabetes mellitus, DM)中可有效改善胰岛β细胞功能及刺激胰岛素的分泌。白藜芦醇的作用机制较为复杂,现就白藜芦醇在DM治疗中的作用及机制作一概述。     

水溶液中白藜芦醇稳定性及降解产物分析

白藜芦醇是一种具有较强抗氧化和防癌、抗癌等生理活性的植物天然产物,其功能与生产是当前的研究热点;然而,白藜芦醇的光稳定性和热稳定性较差。在微生物发酵生产及存储过程中需要采取特殊的工艺,以防止其降解,使得发酵及存储工艺复杂化,增加了成本。本研究对发酵及存储过程中的各类条件,如温度、pH、培养基成分及大肠杆菌对白藜芦醇的降解情况进行了初步的研究;使用液相色谱-离子阱-飞行时间质谱,对白藜芦醇的降解产物进行了分析。本研究可作为基础资料,为降低发酵生产及存储过程中白藜芦醇的降解提供重要参考。     

白藜芦醇代谢物的研究进展

白藜芦醇是一些植物在受到生物和非生物胁迫时产生的一种植物抗毒素.它在植物体内会迅速被代谢而生产紫檀芪、云杉新苷、viniferins等代谢物.这些代谢物与白藜芦醇一样具有抗菌、消炎、抗血小板凝集、防止细胞癌变等一系列的生物活性,且有些代谢物的选择性、稳定性远远大于白藜芦醇.本文对白藜芦醇代谢物中几种主要代谢物的合成途径、生物活性、代谢调控、检测方法等进行了综述.     

白藜芦醇合成酶基因在基因工程中的应用及功能研究进展

白藜芦醇合成酶(Resveratrol synthase,RS)是白藜芦醇(Resveratrol,Res)合成途径中的关键酶。以往研究报道,RS基因已在多种植物和微生物中进行了转化和表达,并在植物的代谢及调控等方面发挥生物学作用。文中主要围绕RS基因对植物的转化,及异源表达后植物体内代谢产物的变化,转RS基因对植物抗病原菌活性、抗自由基活性和生长发育的影响,以及利用RS基因在微生物中生产Res的相关进展进行了综述。并对RS基因在生物工程方面的应用前景进行展望。     

微生物合成白藜芦醇的研究进展

白藜芦醇是植物源的多酚化合物,具有清除自由基、抗氧化、延长寿命等生理活性,在医药、保健品、化妆品等方面有着广阔的应用前景。目前,白藜芦醇主要采用植物提取的方法,对自然植物资源依赖严重,而且受植物成分含量和提取效率低的限制。近年来,合成生物学的迅速发展已使人们将注意力转向利用微生物合成白藜芦醇。通过在微生物中转入外源基因,成功构建出了白藜芦醇工程菌株,并从基因序列、组合方式及发酵工艺等方面进行了优化改造。本文综述了微生物合成白藜芦醇的研究进展。     

异源表达CiRS基因通过生成白藜芦醇增强拟南芥的抗氧化能力

白藜芦醇是一种具有多种医疗保健作用的植物芪类次生代谢产物,在农业、医药、食品和化妆品等领域受到广泛的关注。白藜芦醇合酶是白藜芦醇生物合成中唯一必需的关键酶,决定植物体内白藜芦醇的合成。将中间锦鸡儿中克隆到的CiRS基因(Gen Bank登录号MF678590)转入野生型拟南芥,实验结果显示:野生型的总黄酮含量明显高于转基因株系。HPLC测得转基因拟南芥中有白藜芦醇的生成,并且含量最高达335μg/g FW。紫外照射处理后转基因植物中丙二醛的积累量明显少于野生型。转基因植物提取物DPPH自由基清除能力均高于野生型。这些结果表明,中间锦鸡儿CiRS基因异源表达后利用与黄酮类物质的共同底物合成了白藜芦醇,使得转基因植物的抗氧化性增强。     

白藜芦醇合酶的研究进展

白藜芦醇是一种重要的植物抗毒素,具有多种医疗保健作用,因此其应用前景 非常广泛,已引起多方关注。白藜芦醇合酶是白藜芦醇生物合成途径中的关键酶之一,它催化1分子4-香豆酰辅酶A和3分子丙二酰辅酶A反应合成白藜芦醇,它是白藜芦醇生物合成中惟一必需的酶,关于它的研究已广泛开展起来。本文综述了白藜芦醇的药理活性、白藜芦醇合 酶的酶学性质、诱导途径和机制以及分子生物学方面的研究进展。     

白藜芦醇合酶的研究进展

白藜芦醇是一种重要的植物抗毒素,具有多种医疗保健作用,因此其应用前景非常广泛,已引起多方关注。白藜芦醇合酶是白藜芦醇生物合成途径中的关键酶之一,它催化1分子4—香豆酰辅酶A和3分子丙二酰辅酶A反应合成白藜芦醇,它是白藜芦醇生物合成中惟一必需的酶,关于它的研究已广泛开展起来。本文综述了白藜芦醇的药理活性、白藜芦醇合酶的酶学性质、诱导途径和机制以及分子生物学方面的研究进展。     

大肠杆菌中从头合成白藜芦醇途径的设计及优化

白藜芦醇是一种极具药用价值的植物源芪类化合物。为了在E. coli实现白藜芦醇的从头合成,构建了由酪氨酸解氨酶（TAL）,香豆酸-CoA合成酶（4CL）和白藜芦醇合成酶（STS）组成的非天然合成途径。经3天发酵后,白藜芦醇产量仅为2.67 mg/L,而其中间体香豆酸的积累达到了95.64 mg/L。为了进一步改善异源途径的效率,对4CL和STS模块采取融合表达、高拷贝表达及启动子工程改造的策略,最终使白藜芦醇产量提高到了9.6倍,达到了25.76 mg/L,同时香豆酸的积累减少到了20.38 mg/L。这些研究结果为更高效白藜芦醇从头合成工程菌的构建及最终实现白藜芦醇的微生物大规模生产奠定了基础。     

大肠杆菌中从头合成白藜芦醇途径的设计及优化

白藜芦醇是一种极具药用价值的植物源芪类化合物。为了在E.coli实现白藜芦醇的从头合成,构建了由酪氨酸解氨酶(TAL),香豆酸-CoA合成酶(4CL)和白藜芦醇合成酶(STS)组成的非天然合成途径。经3天发酵后,白藜芦醇产量仅为2.67 mg/L,而其中间体香豆酸的积累达到了95.64 mg/L。为了进一步改善异源途径的效率,对4CL和STS模块采取融合表达、高拷贝表达及启动子工程改造的策略,最终使白藜芦醇产量提高到了9.6倍,达到了25.76 mg/L,同时香豆酸的积累减少到了20.38 mg/L。这些研究结果为更高效白藜芦醇从头合成工程菌的构建及最终实现白藜芦醇的微生物大规模生产奠定了基础。     

Coenzyme Q10 production in plants: current status and future prospects

Coenzyme Q10 (CoQ10) or Ubiquinone10 (UQ10), an isoprenylated benzoquinone, is well-known for its role as an electron carrier in aerobic respiration. It is a sole representative of lipid soluble antioxidant that is synthesized in our body. In recent years, it has been found to be associated with a range of patho-physiological conditions and its oral administration has also reported to be of therapeutic value in a wide spectrum of chronic diseases. Additionally, as an antioxidant, it has been widely used as an ingredient in dietary supplements, neutraceuticals, and functional foods as well as in anti-aging creams. Since its limited dietary uptake and decrease in its endogenous synthesis in the body with age and under various diseases states warrants its adequate supply from an external source. To meet its growing demand for pharmaceutical, cosmetic and food industries, there is a great interest in the commercial production of CoQ10. Various synthetic and fermentation of microbial natural producers and their mutated strains have been developed for its commercial production. Although, microbial production is the major industrial source of CoQ10 but due to low yield and high production cost, other cost-effective and alternative sources need to be explored. Plants, being photosynthetic, producing high biomass and the engineering of pathways for producing CoQ10 directly in food crops will eliminate the additional step for purification and thus could be used as an ideal and cost-effective alternative to chemical synthesis and microbial production of CoQ10. A better understanding of CoQ10 biosynthetic enzymes and their regulation in model systems like E. coli and yeast has led to the use of metabolic engineering to enhance CoQ10 production not only in microbes but also in plants. The plant-based CoQ10 production has emerged as a cost-effective and environment-friendly approach capable of supplying CoQ10 in ample amounts. The current strategies, progress and constraints of CoQ10 production in plants are discussed in this review.     

主要作物光温敏核雄性不育基因的研究进展与应用*

光温敏核雄性不育系在不同的生态环境条件下可以实现一系两用,简化制种程序,是农作物杂交种子生产的一种重要资源。简要介绍了主要作物杂交种子生产方式,综述了水稻、小麦、玉米、谷子等作物光温敏核雄性不育系的研究进展以及在两系杂交种子生产上的应用,并探讨了光温敏核雄性不育系的应用前景。     

Polysaccharide production by a reduced pigmentation mutant of Aureobasidium pullulans NYS-1

AIMS: To isolate a reduced pigmentation mutant of Aureobasidium pullulans NYS-1 and characterize its cellular pigmentation plus its polysaccharide and biomass production relative to carbon source. METHODS AND RESULTS: Cellular pigmentation, polysaccharide levels and biomass production by the isolated mutant NYSRP-1 were analysed relative to carbon source. Cellular pigmentation of the mutant was lower than its parent strain using either carbon source. The mutant elaborated higher polysaccharide levels on sucrose than on corn syrup. The pullulan content of the polysaccharide synthesized and biomass production by the mutant rose as the carbon source concentration was increased. CONCLUSION: It is feasible to isolate a reduced pigmentation mutant from strain NYS-1 that exhibits elevated polysaccharide production using corn syrup as a carbon source. SIGNIFICANCE AND IMPACT OF THE STUDY: The mutant provides an advantage for commercial pullulan production because of its reduced pigmentation and enhanced polysaccharide synthesis.     

Bioreactor and process design for biohydrogen production

Biohydrogen is regarded as an attractive future clean energy carrier due to its high energy content and environmental-friendly conversion. It has the potential for renewable biofuel to replace current hydrogen production which rely heavily on fossil fuels. While biohydrogen production is still in the early stage of development, there have been a variety of laboratory- and pilot-scale systems developed with promising potential. This work presents a review of advances in bioreactor and bioprocess design for biohydrogen production. The state-of-the art of biohydrogen production is discussed emphasizing on production pathways, factors affecting biohydrogen production, as well as bioreactor configuration and operation. Challenges and prospects of biohydrogen production are also outlined.     

生物柴油研究进展

介绍了国内外生物柴油的发展现状,探讨了我国发展生物柴油的原料来源途径,包括木本油料植物、转基因油料作物、废弃油脂、微生物油脂和微藻油脂等,综述了制备生物柴油的化学法、酶法、超临界法等生产技术及其进展,概括了当前生物柴油主要的品质问题与改性对策,分析了生物柴油副产物的高值化利用策略,指出了我国生物柴油产业化面临的原料、技术和生物炼制方面的主要问题。     

Recent advances on biological difructose anhydride III production using inulase II from inulin

Difructose anhydride III (DFA III), the smallest cyclic disaccharide, consists of two fructose residues. DFA III is a hydrolysate of inulin and is rarely found in nature. Industrial interest in DFA III as a low-calorie sugar substitute is increasing. The present review describes the properties and physiological functions of DFA III as well as its commercial importance. Focus is also given on the biological production of DFA III from inulin, which contains enzyme resources, inulase II properties, and the capacity for mass DFA III production. Inulase II as an industrial enzyme and its molecular evolution are discussed as well. The aim is to better understand commercial-scale DFA III production as a food product.     

Brazilian alcohol: Food versus fuel?

The creation of the ProAlcool (National Alcohol Programme) late in 1975 for the production of fuel alcohol has raised varied criticisms as to the possible consequences for food production in Brazil. This food ‘problem’ in Brazil is embedded in its socio-economic and political system. Agricultural production has kept ahead of population growth, but the main beneficiaries have been commodity export crops; the issue can be identified as ‘commodity export crop production versus crop production for the domestic market’ rather than ‘food versus fuel’. The possible effects of the ProAlcool on food production have been exaggerated and the real implications largely overlooked. The sugar and alcohol sector is today among Brazil's largest industries and, with all its faults, the ProAlcool remains the world's most successful biomass energy programme and as such its importance extends beyond Brazil's national boundaries. Biomass has been demonstrated by a Third World country to be a viable alternative or complement to oil on a national scale. Despite the current (1986) low oil prices an interministerial commission has recently recommended that the ProAlcool programme should be maintained.     

棉田生态系统中害虫、天敌群落结构与功能关系的研究

为探讨生物群落结构与功能的关系,有效地开展棉田害虫、天敌的生态调控,作者在系统调查与测定华北棉区８种不同时空类型棉田害虫、天敌群落物种丰富度、总个体数、能流量多样性指数及群落生产力的基础上,分析了各类型棉田害虫、天敌群落结构与功能的关系,总结了如下的一般规律：１）上一营养层（棉株或害虫）的生产力越高,其所支持的下一营养层（害虫或天敌）群落的总个体数和生产力增加;２）害虫群落的物种丰富度与其群落生产     

Phosphorylation of flotillin-1 by mitochondrial c-Src is required to prevent the production of reactive oxygen species

We have shown that mitochondrial c-Src regulates reactive oxygen species (ROS) production by phosphorylating the succinate dehydrogenase A of respiratory complex II (CxII). To elucidate the molecular mechanisms underlying ROS production regulated by c-Src in the CxII, we investigated the CxII protein complex derived from cells treated with Src family kinase inhibitor PP2. We identified flotillin-1 as a c-Src target that prevents ROS production from CxII. Phosphorylation-site analysis suggests Tyr56 and Tyr149 on flotillin-1 as sites for phosphorylation by c-Src. A comparison of cells expressing flotillin-1 and its phosphorylation defective mutants confirms the requirement for flotillin-1 phosphorylation for its interaction with CxII and subsequent reduction in ROS production. Our findings suggest a critical role of flotillin-1 in ROS production mediated by c-Src.     

Animal pharming,two decades on

Since its inception 20 years ago, the animal pharming industry has promoted transgenic animals as a cost-effective method of biopharmaceutical production. However, it took until 2006 for the first therapeutic product to gain regulatory approval. This was an important milestone, but scepticism still abounds. Can pharming regain investor confidence, and will society accept transgenic livestock as a production method? There is some cause for optimism, biopharmaceuticals are a large, expanding market and animal pharming has already made considerable strides. A novel production platform has been established, groundbreaking technologies developed, a necessary regulatory framework put in place. Nevertheless, despite cost advantages, pharming has become a niche production method and its long term success may depend on products unique to transgenic animals.